Meyka Pro banner
Royalty Pharma plc

Stay Updated with the Latest Royalty Pharma plc RPRX News in Real Time

Find RPRX news now at Meyka AI. Stay informed with the latest Royalty Pharma plc stocks updates, including price news, market analysis, and expert insights.

RPRX●NASDAQ
HealthcareMedical - Pharmaceuticals
$56.57
$1.21(2.09%)
U.S. Market opens in 16h 7m
SiriusXM Comedy Backlash: 66% of Comedians Cut as Maniscalco Takes Over October 6
📅 7 days ago

SiriusXM Comedy Backlash: 66% of Comedians Cut as Maniscalco Takes Over October 6

SiriusXM replaced Raw Comedy with Sebastian Maniscalco’s channel, cutting 537 comedians from rotation. Working comics lost $15-per-spin royalties. Patton Oswalt, Michelle Wolf, and others demand restoration.

Read more 12
U.S. Customs Rule Tightens Canadian Drug Imports Starting October 22
📅 8 days ago

U.S. Customs Rule Tightens Canadian Drug Imports Starting October 22

U.S. Customs and Border Protection enforces new rule October 22 requiring declaration of prescription drug imports over $100 from Canada, affecting millions of uninsured Americans seeking affordable medications.

Read more 12
Shell Greenlights $33B LNG Canada Phase 2, Doubling Export Capacity to 28 Mtpa
📅 12 days ago

Shell Greenlights $33B LNG Canada Phase 2, Doubling Export Capacity to 28 Mtpa

Shell approves $33 billion LNG Canada Phase 2 expansion on September 29, doubling facility capacity to 28 mtpa by early 2030s. Meyka grades SHEL as A-rated Buy with 12-month forecast at $91.95.

Read more 12
Swiss GDP Growth Forecast Jumps to 1.7% for 2026 on Pharma Surge
📅 14 days ago

Swiss GDP Growth Forecast Jumps to 1.7% for 2026 on Pharma Surge

Switzerland raises 2026 GDP forecast to 1.7% from 0.9% after Q2 growth hits 1.5%, strongest since 2021. Pharma drives half the gains, but inflation expected to rise.

Read more 12
B.C. Election Set for October 24 After Eby Calls Snap Vote
📅 21 days ago

B.C. Election Set for October 24 After Eby Calls Snap Vote

British Columbia Premier David Eby announced a snap provincial election for October 24, 2026, two years early. The vote follows turmoil in the opposition BC Conservatives and Eby’s concerns over U.S. trade threats.

Read more 12
Sensex Falls 121 Points as Brent Crude Hits $108 on September 11
📅 1 month ago

Sensex Falls 121 Points as Brent Crude Hits $108 on September 11

Sensex fell 121 points to 74,781.76 and Nifty dropped 80 points to 23,398.10 on September 11 as Brent crude jumped to $108 amid West Asia conflict and foreign fund outflows.

Read more 12
Prince Harry Accuses UK of Withholding 2023 Al-Qaeda Threat Upon Return
📅 1 month ago

Prince Harry Accuses UK of Withholding 2023 Al-Qaeda Threat Upon Return

Prince Harry claims UK security officials withheld a 2023 al-Qaeda threat. He returned to Britain last week and is demanding taxpayer-funded police protection for his family.

Read more 12
Sensex Rises 141 Points, Nifty Near 24,100 as IT Stocks Lead Friday’s Intraday Rally
📅 2 months ago

Sensex Rises 141 Points, Nifty Near 24,100 as IT Stocks Lead Friday’s Intraday Rally

The Sensex rose 141.12 points, or 0.18%, to 77,074.71 as of midday trading on Friday, August 28, 2026. The Nifty 50 added 11.60 points to trade at 24,102.45 during the same intraday window. IT stocks led the session as traders awaited Fed Chair Jerome Powell’s Jackson Hole address. These figures reflect an intraday snapshot around…

Read more 12
AstraZeneca (AZN) and Amgen’s Tezspire Succeeds in Late-Stage Oesophagus Disease Trial
📅 2 months ago

AstraZeneca (AZN) and Amgen’s Tezspire Succeeds in Late-Stage Oesophagus Disease Trial

AstraZeneca said Thursday its drug Tezspire met all primary and secondary goals in a late-stage trial. The Phase III CROSSING trial tested Tezspire against placebo in eosinophilic oesophagitis (EoE). AstraZeneca developed the drug jointly with Amgen for this chronic inflammatory oesophagus condition. What the CROSSING Trial Showed The Phase III CROSSING trial evaluated two once-every-four-week…

Read more 12

RPRX News FAQ